AC Immune (ACIU) EBIAT (2016 - 2025)
Historic EBIAT for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.
- AC Immune's EBIAT fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8959.88%. This contributed to the annual value of -$58.1 million for FY2024, which is 493.64% up from last year.
- Latest data reveals that AC Immune reported EBIAT of -$19.8 million as of Q3 2025, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
- In the past 5 years, AC Immune's EBIAT ranged from a high of $6.4 million in Q3 2024 and a low of -$25.6 million during Q2 2025
- In the last 5 years, AC Immune's EBIAT had a median value of -$19.5 million in 2022 and averaged -$17.8 million.
- As far as peak fluctuations go, AC Immune's EBIAT skyrocketed by 13704.81% in 2024, and later tumbled by 41210.51% in 2025.
- Over the past 5 years, AC Immune's EBIAT (Quarter) stood at -$23.1 million in 2021, then increased by 15.65% to -$19.5 million in 2022, then skyrocketed by 72.52% to -$5.3 million in 2023, then plummeted by 237.17% to -$18.0 million in 2024, then decreased by 9.93% to -$19.8 million in 2025.
- Its EBIAT was -$19.8 million in Q3 2025, compared to -$25.6 million in Q2 2025 and -$21.2 million in Q1 2025.